Latest figures show that the growth rate of India's pharma sector dipped to 5.5 per cent in 2017, the lowest in eight years, due to a range of reasons – drug price controls in the domestic market, a fall in exports to the US due to lapses at US Federal Drug Administration-approved labs, and increasing ...
Read more: The reinvention of Indian drug-makers: They're now selling FMCG products